Patient Experience Solutions

The Patient Experience Initiative developed tools to provide more effective ways to engage with patients in the design and execution of clinical studies. These tools aim to improve engagement and partnership between biopharmaceutical companies and patients to create better experiences for clinical study participants.

Find out more below:


Navigate to the Two Patient Experience Toolkits

Click below on the toolkit you would like to know more about.

Design clinical studies with patient inputs
Patient Protocol Engagement Toolkit
(P-PET)

A clinical study engagement toolkit composed of:

  • Sponsor-facing operational user guide*
  • Resource guide* with question bank
  • Templates to enable study sponsors to engage with patients during clinical study design

* These solutions were modified in 2021 to include new considerations for caregivers, and best practices for engaging patients in a virtual environment.

They were modified again in 2022 to include guidance for Key Performance Indicators (KPI), new considerations for patient technology and diversity and inclusion, and customizable visual aids.

The P-PET Toolkit Quick Start Video is available to guide users through key considerations for utilizing the P-PET throughout the patient engagement journey.

Gather patient feedback during clinical studies
Study Participant Feedback Questionnaire Toolkit
(SPFQ)

A clinical study participant feedback toolkit composed of:

  • Socialization Presentation, which includes background information for initial Sponsor discussions
  • Implementation user guide
  • Set of 3 Study Participant Feedback Questionnaires (beginning, during, and end of study) and a Question Bank Addendum

The SPFQ Implementation User Guide and Socialization Presentation were modified to incorporate key learnings from companies that have already implemented the SPFQ.

The SPFQ Question Bank Addendum was added to provide new and replacement questions for SPFQ Version 1.0, addressing motivation to participate, gratitude, and decentralized clinical trial activities.


The Clinical Study

See where P-PET and SPFQ should be used during a clinical study.